5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.81▲ | 0.81▲ | 0.81▲ | 0.78▲ | 0.90▼ |
MA10 | 0.81▼ | 0.81▲ | 0.80▲ | 0.86▼ | 0.79▲ |
MA20 | 0.80▲ | 0.78▲ | 0.77▲ | 0.97▼ | 0.76▲ |
MA50 | 0.76▲ | 0.80▲ | 0.87▼ | 0.81▼ | 1.58▼ |
MA100 | 0.79▲ | 0.95▼ | 0.98▼ | 0.77▲ | 4.02▼ |
MA200 | 0.92▼ | 0.93▼ | 0.84▼ | 1.24▼ | 12.47▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | 0.007▲ | 0.014▲ | -0.035▼ | 0.102▲ |
RSI | 57.067▲ | 53.964▲ | 50.608▲ | 44.114▼ | 41.456▼ |
STOCH | 30.106 | 63.163 | 81.495▲ | 7.799▼ | 41.122 |
WILL %R | -42.927 | -17.426▲ | -17.426▲ | -88.744▼ | -84.545▼ |
CCI | -17.869 | 45.050 | 63.392 | -64.360 | -20.691 |
Thursday, August 07, 2025 06:24 AM
“These results represent a significant milestone for PALI-2108,” said JD Finley, Chief Executive Officer of Palisade Bio. “The early clinical activity, targeted delivery, dose flexibility, the ...
|
Wednesday, July 30, 2025 10:45 PM
Carlsbad, CA, July 31, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio,” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
|
Wednesday, July 30, 2025 05:00 PM
Palisade Bio, Inc. (NASDAQ:PALI – Get Free Report)’s stock price was down 2.8% on Wednesday . The company traded as low as $1.00 and last traded at $1.06. Approximately 261,647 shares were ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 0.847 | 0.847 | 0.7899 | 0.801 | 319,255 |
14/08/25 | 0.833 | 0.835 | 0.79 | 0.815 | 347,650 |
13/08/25 | 0.7418 | 0.84 | 0.7201 | 0.8108 | 942,286 |
12/08/25 | 0.682 | 0.78 | 0.6616 | 0.75 | 999,215 |
11/08/25 | 0.81 | 0.8105 | 0.713 | 0.74 | 1,600,141 |
08/08/25 | 0.8601 | 0.8606 | 0.771 | 0.7901 | 2,870,137 |
07/08/25 | 1.49 | 1.90 | 0.8449 | 0.8784 | 94,980,760 |
06/08/25 | 1.01 | 1.04 | 0.9719 | 1.00 | 200,746 |
05/08/25 | 1.02 | 1.0467 | 1.00 | 1.02 | 76,957 |
04/08/25 | 1.08 | 1.08 | 1.01 | 1.04 | 187,150 |
|
|
||||
|
|
||||
|
|